|
Manufacturer |
Brand Name |
Antigen |
Revision Date |
Package Insert |
Adjuvant or other possible ingredient
with food product in it |
|
Acambis, Inc. |
ACAM2000 |
Smallpox Vaccine, Dried, Calf Lymph
Type |
August 2007 |
ACAM2000 |
Calf liver, lymph,
Glycerin |
|
Berna Biotech, Ltd |
Vivotif |
Typhoid Vaccine Live Oral Ty21a
|
August 2006 |
Vivotif |
|
|
BioPort Corp |
Biothrax |
Anthrax Vaccine Adsorbed |
January 2002 |
Biothrax |
|
|
BioPort Corp |
No Trade Name (RABA) |
Rabies Vaccine Adsorbed |
|
|
? |
|
Chiron Behring GmbH & Co |
RabAvert |
Rabies Vaccine |
April 2004 |
RabAvert |
chicken,bovine
gelatin, antibiotics, bovine serum |
|
CHIRON VACCINES LIMITED |
Fluvirin |
Influenza Virus Vaccine, Trivalent,
Types A and B |
May 2006 |
Fluvirin |
chicken eggs |
|
CSL Limited |
AFLURIA |
Influence Virus Vaccine |
September 2007 |
AFLURIA |
chicken eggs,
phosphate buffered isotonic solution |
|
GlaxoSmithKline |
Boostrix |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccine, Adsorbed |
April 2008 |
Boostrix |
aluminum adjuvant,
latex on tip cap, modified Latham medium derived from bovine casein,
modified Stainer-Scholte liquid medium |
|
GlaxoSmithKline |
Engerix-B |
Hepatitis B Vaccine (Recombinant) |
December 2006 |
Engerix-B |
adsorbed on 0.25 mg aluminum as aluminum hydroxide? |
|
GlaxoSmithKline |
Fluarix |
Influenza Virus Vaccine, Trivalent,
Types A and B |
August 2007 |
Fluarix |
|
|
GlaxoSmithKline |
FluLaval |
Influenza Virus Vaccine |
August 2007 |
FluLaval |
Each dose may also contain
residual amounts of egg proteins
|
|
GlaxoSmithKline |
Havrix |
Hepatitis A Vaccine, Inactivated |
March 2008 |
Havrix |
cell culture medium, adsorbed onto 0.25 mg of aluminum as
aluminum hydroxide. |
|
GlaxoSmithKline |
Infanrix |
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Adsorbed |
March 2008 |
Infanrix |
aluminum adjuvant; Fenton medium containing
a bovine extract; modified Latham medium derived from bovine casein;
modified Stainer-Scholte liquid medium |
|
GlaxoSmithKline |
Kinrix |
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Adsorbed and Inactivated Poliovirus Vaccine Combined |
June 2008 |
Kinrix |
Fenton 181 medium containing a bovine extract, modified
Latham medium derived from bovine casein, modified Stainer-Scholte liquid
medium, adsorbed onto aluminum hydroxide, monkey kidney cells,
aluminum adjuvant
|
|
GlaxoSmithKline |
Pediarix |
Diphtheria & Tetanus Toxoids &
Acellular Pertussis Vaccine Adsorbed, Hepatitis B (recombinant) and
nactivated Poliovirus Vaccine |
June 2007 |
Pediarix |
aluminum adjuvant; Fenton medium containing
a bovine extract; modified Latham medium derived from bovine casein;
modified Stainer-Scholte liquid medium; monkey kidney cells; Calf serum
|
|
GlaxoSmithKline |
Rotarix |
Rotavirus Vaccine, Live, Oral Hepatitis A Inactivated and
Hepatitis B (Recombinant) Vaccine |
April 2008 |
Rotarix |
propagated on Vero cells; Dulbecco’s Modified Eagle Medium (DMEM); latex
rubber |
|
GlaxoSmithKline |
Twinrix |
Hepatitis A Inactivated and Hepatitis B (Recombinant) Vaccine
|
April 2007 |
Twinrix |
aluminum phosphate and aluminum hydroxide as
adjuvants |
|
ID Biomedical Corp of Quebec FluLaval
|
|
Influenza Virus Vaccine, Trivalent,
Types A and B |
August 2008 |
FluLaval |
Each dose may also contain residual amounts of egg proteins |
|
Massachusetts Public Health Biologic
Lab |
No Trade Name (TD) |
Tetanus & Diphtheria Toxoids Adsorbed
for Adult Use |
|
|
|
|
Massachusetts Public Health Biologic
Lab |
No Trade Name (TTOXa) |
Tetanus Toxoid Adsorbed |
|
|
|
|
MedImmune Vaccines, Inc |
FluMist |
Influenza Virus Vaccine, Live,
Intranasal |
June 2008 |
FluMist |
|
|
Merck & Co |
Attenuvax |
Measles Virus Vaccine, Live |
February 2006 |
Attenuvax |
chick embryo cell culture, fetal bovine serum,
gelatin, other buffer, and media ingredients |
|
Merck & Co |
Gardasil |
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18)
Recombinant Vaccine |
December 2007 |
Gardasil |
aluminum-containing adjuvant;
chemically-defined fermentation media; < 7 mcg
yeast protein/dose |
|
Merck & Co |
Meruvax II |
Rubella Virus Vaccine Live |
February 2006 |
Meruvax II |
fetal bovine serum, gelatin |
|
Merck & Co |
M-M-R II |
Measles, Mumps, and Rubella Virus Vaccine, Live |
December 2007 |
M-M-R II |
chick embryo cell culture, fetal bovine serum,
Minimum Essential Medium, other buffer and media ingredients |
|
Merck & Co |
M-M-Vax |
Measles and Mumps Virus Vaccine, Live |
September 2002 |
M-M-Vax |
chick embryo cell culture, fetal bovine serum,
hydrolyzed gelatin, other buffer and media ingredients |
|
Merck & Co |
Mumpsvax |
Mumps Virus Vaccine Live |
September 2002 |
Mumpsvax |
chick embryo cell culture, fetal bovine serum,
hydrolyzed gelatin, other buffer and media ingredients |
|
Merck & Co |
PedvaxHIB |
Haemophilus b Conjugate Vaccine (Meningococcal Protein
Conjugate) |
January 2001 |
PedvaxHIB |
complex fermentation media |
|
Merck & Co |
Pneumovax 23 |
Pneumococcal Vaccine, Polyvalent |
July 2008 |
Pneumovax 23 |
isotonic saline solution, manufactured
according to methods |
|
Merck & Co |
ProQuad |
Measles, Mumps, Rubella and Varicella Virus Vaccine Live
|
February 2008 |
ProQuad |
sterile lyophilized preparation, chick embryo
cell culture, hydrolyzed gelatin, monosodium L-glutamate, residual
components of MRC-5 cells including DNA and protein; <16 mcg of neomycin,
bovine calf serum, (0.5 mcg), and other buffer and media ingredients |
|
Merck & Co |
Recombivax HB |
Hepatitis B Vaccine (Recombinant) |
December 2007 |
Recombivax HB |
produced in yeast cells, cloned into yeast,
complex fermentation medium which consists of an extract of yeast, soy
peptone, adjuvanted with amorphous
aluminum, hydroxyphosphate sulfate, may contain not more than 1%
yeast protein |
|
Merck & Co |
RotaTeq |
Rotavirus Vaccine, Live, Oral, Pentavalent |
April 2008 |
RotaTeq |
bovine hosts, propagated in Vero cells using
standard cell culture techniques, buffered stabilizer solution, cell culture
media, and trace amounts of fetal bovine serum |
|
Merck & Co |
VAQTA |
Hepatitis A Vaccine, Inactivated |
December 2007 |
VAQTA |
grown in cell culture, adsorbed onto amorphous
aluminum hydroxyphosphate sulfate, bovine albumin,
adsorbed onto approximately 0.225 mg
of aluminum provided as amorphous aluminum hydroxyphosphate sulfate,
and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride |
|
Merck & Co |
Varivax |
Varicella Virus Vaccine Live |
March 2008 |
Varivax |
cultures; processed gelatin; monosodium
L-glutamate; fetal bovine serum |
|
Merck & Co |
Zostavax |
Zoster Vaccine, Live, (Oka/Merck) |
June 2008 |
Zostavax |
hydrolyzed porcine gelatin; monosodium
L-glutamate; residual components of MRC-5 cells; including DNA and protein;
and trace quantities of neomycin and bovine calf serum |
|
Merck & Co, Inc |
Comvax |
Haemophilus b Conjugate Vaccine
(Meningococcal Protein Conjugate) & Hepatitis B Vaccine Recombinant)
|
August 2004 |
Comvax |
recombinant
yeast cultures; complex fermentation media; soy peptone; adsorbed onto an
amorphous aluminum hydroxyphosphate sulfate adjuvant (previously referred to
as aluminum hydroxide); complex fermentation medium which consists of an
extract of yeast, soy peptone, dextrose, amino acids and mineral salts
coprecipitated with alum (potassium aluminum sulfate) to form bulk vaccine
adjuvanted with amorphous aluminum
hydroxyphosphate sulfate |
|
Organon Teknika Corp |
TICE BCG |
BCG Live |
|
|
|
|
Research Foundation for Microbial Diseases of Osaka
University |
JE-Vax |
Japanese Encephalitis Virus Vaccine Inactivated |
December 2005 |
JE-Vax |
prepared by inoculating mice
intracerebrally; gelatin; mouse serum protein; homogenized in phosphate
buffered saline |
|
Sanofi Pasteur |
ActHIB |
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
|
December 2005 |
ActHIB |
semi-synthetic medium; modified
Mueller and Miller medium; saline diluent |
|
Sanofi Pasteur |
Adacel |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccine, Adsorbed |
March 2008 |
Adacel |
? bad link |
|
Sanofi Pasteur |
DAPTACEL |
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Adsorbed |
March 2008 |
DAPTACEL |
dry natural latex rubber; aluminum
phosphate (0.33 mg of aluminum) as the adjuvant; Stainer-Scholte medium;
supernatant culture medium; Mueller’s growth medium; beef heart;
aluminum phosphate (as adjuvant) |
|
Sanofi Pasteur |
DECAVAC |
Tetanus & Diphtheria Toxoids Adsorbed for Adult Use
|
December 2005 |
DECAVAC |
alum-precipitated (aluminum
potassium sulfate); modified Mueller and Miller medium; peptone-based
medium containing an extract of bovine muscle tissue. |
|
Sanofi Pasteur |
Fluzone |
Influenza Virus Vaccine, Trivalent,
Types A and B |
June 2008 |
Fluzone |
embryonated chicken eggs; sodium
phosphate-buffered isotonic; sodium chloride solution; Gelatin |
|
Sanofi Pasteur |
Fluzone, No preservative |
Influenza Virus Vaccine, Trivalent,
Types A and B Preservative free) |
June 2008 |
|
|
|
Sanofi Pasteur |
Fluzone, No perservative, Ped dose
|
Influenza Virus Vaccine, Trivalent,
Types A and B Preservative free, Pediatric Dose) |
June 2008 |
|
|
|
Sanofi Pasteur |
Imovax |
Rabies Vaccine |
December 2005 |
Imovax |
harvested from infected human
diploid cells, MRC-5 strain? |
|
Sanofi Pasteur |
IPOL |
Poliovirus Vaccine Inactivated (Monkey Kidney Cell)
|
December 2005 |
IPOL |
grown in vero cells; monkey kidney
cells cultivated on microcarriers; Eagle MEM modified medium; culture medium
is replaced by M-199; residual calf serum protein is less than 1 ppm in the
final vaccine |
|
Sanofi Pasteur |
Menactra |
Meningococcal Polysaccharide (Serogroups A, C, Y and W-135)
Diphtheria Toxoid Conjugate Vaccine |
October 2007 |
Menactra |
cultured on Mueller; Hinton agar1
and grown in Watson Scherp2
media; modified Mueller and
Miller medium |
|
Sanofi Pasteur |
Menomune-A/C/Y/W-135 |
Meningococcal Polysaccharide Vaccine,
Groups A, C, Y and W-135 Combined |
December 2005 |
Menomune-A/C/Y/W-135 |
Mueller Hinton agar1
and Watson Scherp2
media; lactose |
|
Sanofi Pasteur |
Mycobax |
BCG Live |
|
|
|
|
Sanofi Pasteur |
No Trade Name (DT) |
Diphtheria & Tetanus Toxoids Adsorbed (pediatric use)
|
December 2005 |
No Trade Name (DT) |
sterile suspension
of alum-precipitated (aluminum potassium sulfate); modified Mueller
and Miller medium; bovine extract. |
|
Sanofi Pasteur |
No Trade Name (H5N1) |
Influenza Virus Vaccine, H5N1 |
April 2007 |
No Trade Name (H5N1) |
embryonated chicken eggs; suspended in sodium
phosphate-buffered isotonic sodium chloride solution. |
|
Sanofi Pasteur |
No Trade Name (TD) |
Tetanus & Diphtheria Toxoids Adsorbed for Adult Use
|
June 1996 |
No Trade Name (TD) |
aluminum phosphate
(0.33 mg of aluminum) as the adjuvant; modified Mueller-Miller
casamino acid medium; modified Mueller’s growth medium;
aluminum phosphate (as 227 adjuvant)
|
|
Sanofi Pasteur |
No Trade Name (TTOX) |
Tetanus Toxoid |
December 2005 |
No Trade Name (TTOX) |
isotonic sodium chloride solution;
peptone-based medium |
|
Sanofi Pasteur |
No Trade Name (TTOXa) |
Tetanus Toxoid Adsorbed |
December 2005 |
No Trade Name (TTOXa) |
peptone-based medium containing an
extract of bovine muscle tissue;
aluminum potassium sulfate (alum) |
|
Sanofi Pasteur |
Pentacel |
Diphtheria and Tetanus Toxoids and Acellular Pertussis
Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid
Conjugate) Vaccine |
June 2008 |
Pentacel |
aluminum phosphate (0.33 mg
aluminum) as the adjuvant; modified Mueller’s growth medium; modified
Mueller-Miller casamino acid medium; grown in Stainer-Scholte medium;
separate cultures of MRC-5 cells; Medium 199; semi-synthetic medium;
modified Mueller and Miller medium |
|
Sanofi Pasteur |
Poliovax |
Poliovirus Vaccine Inactivated (Human Diploid Cell)
|
|
|
|
|
Sanofi Pasteur |
Tripedia |
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Adsorbed |
December 2005 |
Tripedia |
isotonic sodium chloride solution;
modified Mueller and Miller medium; peptone-based medium containing a bovine
extract; modified Stainer-Scholte medium;
adsorbed using aluminum potassium
sulfate (alum); gelatin |
|
Sanofi Pasteur |
TYPHIM Vi |
Typhoid Vi Polysaccharide Vaccine |
December 2005 |
TYPHIM Vi |
semi-synthetic medium without
animal proteins |
|
Sanofi Pasteur |
YF-Vax |
Yellow Fever Vaccine |
February 2008 |
YF-Vax |
chicken embryos; gelatin |
|
Wyeth Pharmaceuticals, Inc. |
Dryvax |
Smallpox Vaccine, Dried, Calf Lymph Type |
June 2007 |
Dryvax |
calf lymph; During processing, polymyxin B sulfate,
dihydrostreptomycin sulfate, chlortetracycline hydrochloride, and neomycin
sulfate are added, and trace amounts of these antibiotics may be present in
the final product; glycerin |
|
Wyeth Pharmaceuticals, Inc. |
HibTITER |
Haemophilus b Conjugate Vaccine (Diphtheria CRM197 Protein
Conjugate) |
January 2007 |
HibTITER |
chemically defined medium (a mixture of mineral salts, amino
acids, and cofactors); casamino acids and yeast extract-based medium |
|
Wyeth Pharmaceuticals, Inc. |
Prevnar |
Pneumococcal 7-valent Conjugate Vaccine |
December 2007 |
Prevnar |
soy peptone broth; casamino
acids and yeast extract-based medium;
aluminum phosphate adjuvant |